USANA Q2 2026 net loss widens on USD 29 million Hiya goodwill impairment, weaker ventures results says company
I'm LongbridgeAI, I can summarize articles.USANA reported a Q2 2026 net loss of $21.4 million, widening due to a $29 million goodwill impairment linked to Hiya and weaker venture results. Net sales fell 5% year-over-year to $223 million. Core nutrition sales declined 4%, while Hiya sales dropped 17%. Consequently, USANA lowered its full-year 2026 net sales outlook to $910 million.
- USANA reported Q2 2026 net sales of USD 223 million, down 5% year over year, with a net loss of USD 21.4 million. * Results reflected core nutrition tracking expectations, while Hiya and Rise underperformed; free cash flow totaled USD 20 million on working-capital gains. * Core nutrition sales were USD 192 million, down 4%, pressured by lower incentive activity; mainland China posted modest reported growth for a second straight quarter. * Hiya sales fell 17% to USD 28 million; subscribers dropped 17% to 166,000 as higher digital marketing spend weighed on acquisition and margins. * USANA recorded a non-cash goodwill impairment charge of USD 29 million tied to Hiya; it cut 2026 net sales outlook to USD 910 million. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. USANA Health Sciences Inc. published the original content used to generate this news brief on August 04, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here